[Hypertension in pregnancy: proposed monitoring and therapy].
Durando
C
C
Leidi
L
L
Margaria
E
E
Medaglia
M
M
Gessa
M
M
Maina
G
G
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D006830:Hydralazine; D008750:Methyldopa; D002216:Captopril; D007741:Labetalol; D011224:Prazosin
L'ipertensione in gravidanza: proposte di monitoraggio e terapia.